News
QPTFF
0.040
NaN%
--
Weekly Report: what happened at QPTFF last week (0609-0613)?
Weekly Report · 5d ago
Weekly Report: what happened at QPTFF last week (0602-0606)?
Weekly Report · 06/09 10:29
Weekly Report: what happened at QPTFF last week (0526-0530)?
Weekly Report · 06/02 10:34
Weekly Report: what happened at QPTFF last week (0519-0523)?
Weekly Report · 05/26 10:34
Weekly Report: what happened at QPTFF last week (0512-0516)?
Weekly Report · 05/19 10:27
Weekly Report: what happened at QPTFF last week (0505-0509)?
Weekly Report · 05/12 10:28
Weekly Report: what happened at QPTFF last week (0428-0502)?
Weekly Report · 05/05 10:29
Weekly Report: what happened at QPTFF last week (0421-0425)?
Weekly Report · 04/28 10:36
Weekly Report: what happened at QPTFF last week (0414-0418)?
Weekly Report · 04/21 10:35
Weekly Report: what happened at QPTFF last week (0407-0411)?
Weekly Report · 04/14 10:29
Weekly Report: what happened at QPTFF last week (0331-0404)?
Weekly Report · 04/07 10:28
Weekly Report: what happened at QPTFF last week (0324-0328)?
Weekly Report · 03/31 10:35
Weekly Report: what happened at QPTFF last week (0317-0321)?
Weekly Report · 03/24 10:28
Weekly Report: what happened at QPTFF last week (0310-0314)?
Weekly Report · 03/17 10:34
Weekly Report: what happened at QPTFF last week (0303-0307)?
Weekly Report · 03/10 10:36
Weekly Report: what happened at QPTFF last week (0224-0228)?
Weekly Report · 03/03 10:35
Weekly Report: what happened at QPTFF last week (0217-0221)?
Weekly Report · 02/24 10:35
Weekly Report: what happened at QPTFF last week (0210-0214)?
Weekly Report · 02/17 10:33
Weekly Report: what happened at QPTFF last week (0203-0207)?
Weekly Report · 02/10 10:29
Weekly Report: what happened at QPTFF last week (0127-0131)?
Weekly Report · 02/03 10:33
More
Webull provides a variety of real-time QPTFF stock news. You can receive the latest news about Quest Pharmatech through multiple platforms. This information may help you make smarter investment decisions.
About QPTFF
Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The Company also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.